Oakworth Capital, Inc. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 22 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Oakworth Capital, Inc. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$5,768
+28.6%
3,0520.0%0.00%
Q2 2023$4,486
-24.6%
3,0520.0%0.00%
-100.0%
Q1 2023$5,951
-13.3%
3,0520.0%0.00%0.0%
Q4 2022$6,867
-1.9%
3,0520.0%0.00%0.0%
Q3 2022$7,000
+16.7%
3,0520.0%0.00%0.0%
Q2 2022$6,000
-33.3%
3,0520.0%0.00%0.0%
Q1 2022$9,000
-35.7%
3,0520.0%0.00%0.0%
Q4 2021$14,000
+75.0%
3,0520.0%0.00%0.0%
Q3 2021$8,000
-11.1%
3,0520.0%0.00%0.0%
Q2 2021$9,0000.0%3,0520.0%0.00%0.0%
Q1 2021$9,0000.0%3,0520.0%0.00%0.0%
Q4 2020$9,000
-10.0%
3,0520.0%0.00%
-50.0%
Q3 2020$10,0000.0%3,0520.0%0.00%0.0%
Q2 2020$10,000
-9.1%
3,0520.0%0.00%
-33.3%
Q1 2020$11,000
-31.2%
3,0520.0%0.00%0.0%
Q4 2019$16,000
-11.1%
3,0520.0%0.00%0.0%
Q3 2019$18,000
-5.3%
3,0520.0%0.00%
-25.0%
Q2 2019$19,000
+5.6%
3,0520.0%0.00%0.0%
Q1 2019$18,0000.0%3,0520.0%0.00%0.0%
Q4 2018$18,000
+5.9%
3,0520.0%0.00%
+33.3%
Q3 2018$17,000
-10.5%
3,0520.0%0.00%
-25.0%
Q2 2018$19,000
-5.0%
3,0520.0%0.00%
-20.0%
Q1 2018$20,000
-9.1%
3,0520.0%0.01%0.0%
Q4 2017$22,000
+4.8%
3,0520.0%0.01%0.0%
Q3 2017$21,0000.0%3,0520.0%0.01%
-16.7%
Q2 2017$21,0000.0%3,0520.0%0.01%0.0%
Q1 2017$21,000
+23.5%
3,0520.0%0.01%0.0%
Q4 2016$17,000
+13.3%
3,0520.0%0.01%
+20.0%
Q3 2016$15,000
+7.1%
3,0520.0%0.01%0.0%
Q2 2016$14,0000.0%3,0520.0%0.01%
-16.7%
Q1 2016$14,000
-12.5%
3,0520.0%0.01%
-14.3%
Q4 2015$16,000
-11.1%
3,0520.0%0.01%
-22.2%
Q3 2015$18,000
-5.3%
3,0520.0%0.01%0.0%
Q2 2015$19,000
-5.0%
3,0520.0%0.01%0.0%
Q1 2015$20,000
+11.1%
3,0520.0%0.01%0.0%
Q4 2014$18,000
+12.5%
3,0520.0%0.01%0.0%
Q3 2014$16,000
+14.3%
3,0520.0%0.01%0.0%
Q2 2014$14,0000.0%3,0520.0%0.01%0.0%
Q1 2014$14,000
-12.5%
3,0520.0%0.01%
-18.2%
Q4 2013$16,0003,0520.01%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders